|
[Related PubMed/MEDLINE]
Total Number of Papers: 344
|
|
|
| |
|
[Display Entries]
|
|
>> all entries
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
Circular RNA expression profile of H2O2 induced ferroptosis model of human coronary artery endothelial cells. |
CAD, circRNAs, Fer-1, LDH, Lipid ROS, MDA |
| 2 |
2023 |
Ginsenoside Rg1 ameliorates chronic intermittent hypoxia-induced vascular endothelial dysfunction by suppressing the formation of mitochondrial reactive oxygen species through the calpain-1 pathway. |
CIH, NO, OSA, ROS, VED |
| 3 |
2023 |
The role of FOXO4/NFAT2 signaling pathway in dysfunction of human coronary endothelial cells and inflammatory infiltration of vasculitis in Kawasaki disease. |
FOXO4, KD, PBMCs, TF |
| 4 |
2022 |
Apolipoprotein A-I Inhibits Transendothelial Transport of Apolipoprotein B-Carrying Lipoproteins and Enhances Its Associated High-Density Lipoprotein Formation. |
ABCA1, ALK1, apoB-LPs, HDL, MAECs, SR-BI |
| 5 |
2022 |
Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy. |
BEC-EVs, CCP, COVID-19 |
| 6 |
2022 |
Co-culture of peripheral blood mononuclear cell (PBMC) and human coronary artery endothelial cell (HCAEC) reveals the important role of autophagy implicated in Kawasaki disease. |
3-MA, HCAEC, KD, PBMC, PBMCs |
| 7 |
2022 |
Ex vivo coronary endothelial cell activation associated with indoor coal combustion initiated atherosclerosis. |
ELISA, PSM |
| 8 |
2022 |
HADH may be the target molecule of early vascular endothelial impairment in T2DM. |
AS, DEGs, GEO, qPCR, ROC curve, T2DM, VECD, WGCNA |
| 9 |
2022 |
Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease. |
CALs, DAMPs, IL, KD, sST2 |
| 10 |
2022 |
iTRAQ Proteomics Identified the Potential Biomarkers of Coronary Artery Lesion in Kawasaki Disease and In Vitro Studies Demonstrated That S100A4 Treatment Made HCAECs More Susceptible to Neutrophil Infiltration. |
CAL, CAT, ELISA, iTRAQ, KD |
| 11 |
2022 |
Kawasaki disease: ubiquitin-specific protease 5 promotes endothelial inflammation via TNFalpha-mediated signaling. |
KD, NF-kappaB, USP5 |
| 12 |
2022 |
Melatonin alleviates vascular endothelial cell damage by regulating an autophagy-apoptosis axis in Kawasaki disease. |
CAWS, CREB, ELISA, KD, MT |
| 13 |
2022 |
Normoxic HIF-1α Stabilization Caused by Local Inflammatory Factors and Its Consequences in Human Coronary Artery Endothelial Cells. |
HIF |
| 14 |
2022 |
Platelet-derived extracellular vesicles encapsulate microRNA-34c-5p to ameliorate inflammatory response of coronary artery endothelial cells via PODXL-mediated P38 MAPK signaling pathway. |
CAD, EVs, IL-1beta, miR-34c-5p, ox-LDL, PODXL, TNF-alpha |
| 15 |
2022 |
Platelet-derived microRNA-223 attenuates TNF-alpha induced monocytes adhesion to arterial endothelium by targeting ICAM-1 in Kawasaki disease. |
EC, ICAM-1, KD, LCWE, PMPs |
| 16 |
2022 |
Possible causes of atherosclerosis: lncRNA COLCA1 induces oxidative stress in human coronary artery endothelial cells and impairs wound healing. |
COLCA1, LDL, ox-LDL, SPP1 |
| 17 |
2022 |
Protective effect of Astragaloside IV on chronic intermittent hypoxia-induced vascular endothelial dysfunction through the calpain-1/SIRT1/AMPK signaling pathway. |
AS-IV, CIH, NO, OSA, SRT1720, VED |
| 18 |
2022 |
SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways. |
CaM, DAPA, eNOS, IRI, SERCA2, XO |
| 19 |
2022 |
Targeting Circulating lncRNA ENST00000538705.1 Relieves Acute Coronary Syndrome via Modulating ALOX15. |
ACS |
| 20 |
2022 |
The effects and mechanisms of ghrelin upon angiogenesis in human coronary artery endothelial cells under hypoxia. |
Ang-1, Ang-2, GHS-R, VEGF |
| 21 |
2022 |
Transcription factor GATA1 represses oxidized-low density lipoprotein-induced pyroptosis of human coronary artery endothelial cells. |
AS, CVDs, GATA1, GSDMD-N, IL, NLRP3, ox-LDL, RORalpha |
| 22 |
2022 |
Yes-associated protein contributes to magnesium alloy-derivedinflammation in endothelial cells. |
Mg alloy, YAP |
| 23 |
2022 |
Zhilong Huoxue Tongyu Capsule Alleviated the Pyroptosis of Vascular Endothelial Cells Induced by ox-LDL through miR-30b-5p/NLRP3. |
AS, ox-LDL |
| 24 |
2022 |
[Recombinant human interleukin 35 (rhIL-35) alleviates the damage of coronary artery endothelial cells in Kawasaki disease by inhibiting NF-kappaB pathway]. |
KD, NF-kappaB p65, rhIL-35, TNF-alpha, ZO-1 |
| 25 |
2021 |
A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis. |
Ad-KLK8, EndMT, HIF, KLKs, siRNA, Sp1, TGF, VE |
| 26 |
2021 |
Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of ceramides. |
LEVs, nSMase2, sEVs |
| 27 |
2021 |
Adiponectin forms a complex with atherogenic LDL andinhibits its downstream effects. |
CHO, ELISAs, LDL, LOX-1, oxLDL |
| 28 |
2021 |
Antimicrobial Properties of Palladium and Platinum Nanoparticles: A New Tool for Combating Food-Borne Pathogens. |
HaCaT, HDFs, HRTECs, NPs, TEM |
| 29 |
2021 |
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology. |
ECM, HCFs, hiPSC-CMs or iCMs |
| 30 |
2021 |
CUL5-Mediated Visfatin (NAMPT) Degradation Blocks Endothelial Proliferation and Angiogenesis via the MAPK/PI3K-AKT Signaling. |
NAMPT, VEGF |
| 31 |
2021 |
Empagliflozin reduces oxidative stress through inhibition of the novel inflammation/NHE/[Na+]c/ROS-pathway in human endothelial cells. |
EMPA, HUVECs, NHE, ROS, SGLT2i's |
| 32 |
2021 |
Expansion of Monocytic Myeloid-Derived Suppressor Cells in Patients Under Hemodialysis Might Lead to Cardiovascular and Cerebrovascular Events. |
M-MDSCs, MDSCs, OS |
| 33 |
2021 |
Extracellular-vesicle containing miRNA-503-5p released by macrophages contributes to atherosclerosis. |
EVs, miR-503-5p, SMCs |
| 34 |
2021 |
Gastrin exerts a protective effect against myocardial infarction via promoting angiogenesis. |
CCK2R, LAD, MI, VEGF |
| 35 |
2021 |
Immobilization of Glycogen Synthase Kinase-3beta Inhibitor on 316L Stainless Steel via Polydopamine to Accelerate Endothelialization. |
FTIR, GSKi, SEM |
| 36 |
2021 |
LncRNA TONSL-AS1 participates in coronary artery disease by interacting with miR-197. |
CAD, HDL-C, LDL-C, lncRNA |
| 37 |
2021 |
Lysophosphatidylcholine in phospholipase A2-modified LDL triggers secretion of angiopoietin 2. |
Ang-2, PLA2, WPB |
| 38 |
2021 |
MicroRNA-17-5p, a novel endothelial cell modulator, controls vascular re-endothelialization and neointimal lesion formation. |
ECs |
| 39 |
2021 |
MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease. |
IPA, KD, miR-197-3p |
| 40 |
2021 |
Molecular mechanism of Chuanxiong Rhizoma in treating coronary artery diseases. |
CAD, CR, NO |
| 41 |
2021 |
Nanostructured Lipid Carriers Deliver Resveratrol, Restoring Attenuated Dilation in Small Coronary Arteries, via the AMPK Pathway. |
AMPK, L-NNA, NLCs, RV |
| 42 |
2021 |
Neutrophil-Derived Semaphorin 4D Induces Inflammatory Cytokine Production of Endothelial Cells via Different Plexin Receptors in Kawasaki Disease. |
CALs, ECs, KD, Sema4D, sSema4D |
| 43 |
2021 |
Overexpressed Neuropilin-1 in Endothelial Cells Promotes Endothelial Permeability through Interaction with ANGPTL4 and VEGF in Kawasaki Disease. |
ANGPTL4, EC, KD, NRP-1, sNRP1, VEGF, VEGFR2 |
| 44 |
2021 |
Oxidative Phosphorylation-Mediated E-Selectin Upregulation Is Associated With Endothelia-Monocyte Adhesion in Human Coronary Artery Endothelial Cells Treated With Sera From Patients With Kawasaki Disease. |
KD, OXPHOS |
| 45 |
2021 |
PDSS2 Inhibits the Ferroptosis of Vascular Endothelial Cells in Atherosclerosis by Activating Nrf2. |
AS |
| 46 |
2021 |
Platelet Microparticles Enriched in miR-223 Reduce ICAM-1-Dependent Vascular Inflammation in Septic Conditions. |
ICAM-1, LDPs, miRNAs, PBMCs, PMPs, TRAP |
| 47 |
2021 |
Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes. |
conEAT, CPs, EAT, gplEAT, IFNA2, IL-13, IL-5, IL1B, TNF-alpha |
| 48 |
2021 |
Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease. |
ERK, HMGB1, IL, JNK, KD, NF-kappaB, PSL, sJIA, TNF |
| 49 |
2021 |
Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species. |
CANA, DAPA, EMPA, NAC, NOXs, ROS |
| 50 |
2021 |
Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway. |
TSA |
| 51 |
2020 |
Activation of the CaR-CSE/H2S pathway confers cardioprotection against ischemia-reperfusion injury. |
CaR, I/R, siCSE |
| 52 |
2020 |
Aspirin protects human coronary artery endothelial cells by inducing autophagy. |
Ang II, ECs, HG, NO, ox-LDL, p-NF-kappaB, p-p38 MAPK, sICAM-1, sVCAM-1 |
| 53 |
2020 |
Attenuation of Tumor Necrosis Factor-alpha Induced Inflammation by Umbilical Cord-Mesenchymal Stem Cell Derived Exosome-Mimetic Nanovesicles in Endothelial Cells. |
FT, NVs, TFF, TNF-alpha, UC-MSCs |
| 54 |
2020 |
CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation. |
ICAM-1, IL-6, NF-kappaB, oxLDL, TNF, VCAM-1 |
| 55 |
2020 |
Coronary endothelial dysfunction prevented by small-conductance calcium-activated potassium channel activator in mice and patients with diabetes. |
MHECs, ND |
| 56 |
2020 |
Diagnostic Utility and Pathogenic Role of Circulating MicroRNAs in Vasospastic Angina. |
eNOS, miR, VA, VA |
| 57 |
2020 |
DNA hypermethylation: A novel mechanism of CREG gene suppression and atherosclerogenic endothelial dysfunction. |
5-aza-dC, DNMT, HUVECs, NAC, ox-LDL |
| 58 |
2020 |
Fatty-Acid-Binding Protein 4 as a Novel Contributor to Mononuclear Cell Activation and Endothelial Cell Dysfunction in Atherosclerosis. |
CAD, FABP4, MNCs, ox-LDL |
| 59 |
2020 |
Functional benefits of corticosteroid and IVIG combination therapy in a coronary artery endothelial cell model of Kawasaki disease. |
DEX, G-CSF, HMGB1, IVIG, KD, qPCR |
| 60 |
2020 |
Hyperbaric oxygen activates visfatin expression and angiogenesis via angiotensin II and JNK pathway in hypoxic human coronary artery endothelial cells. |
Ang II, HBO, HIF-1alpha, JNK |
| 61 |
2020 |
Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis via ATF2 downregulation. |
ECs, HFD, HIF1A-AS2, ICAM-1, IL-1beta, IL-6, lncRNAs, MCP-1, SMCs, TNF-alpha, VCAM-1 |
| 62 |
2020 |
Monomeric C-reactive protein affects cell injury and apoptosis through activation of p38 mitogen-activated protein kinase in human coronary artery endothelial cells. |
COX-2, CRP, ICAM-2, LDH, MAPK, mCRP, pCRP, VCAM-1, VEGF |
| 63 |
2020 |
NEAT1/miR-140-3p/MAPK1 mediates the viability and survival of coronary endothelial cells and affects coronary atherosclerotic heart disease. |
CAD, lncRNA, MAPK1, NEAT1 |
| 64 |
2020 |
Neutrophil Extracellular Traps Induce MCP-1 at the Culprit Site in ST-Segment Elevation Myocardial Infarction. |
CCR2, CitH3, MCP, NETs, STEMI |
| 65 |
2020 |
Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K/Akt/eNOS pathway. |
AMI, HHcy, LVEF, LVFS, NOS, PI3K |
| 66 |
2020 |
Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells. |
Cana, DAPA, EMPA, HKII, IL-6, IL-6, LPS |
| 67 |
2020 |
Orai-IGFBP3 signaling complex regulates high-glucose exposure-induced increased proliferation, permeability, and migration of human coronary artery endothelial cells. |
HG, IGFBP3 |
| 68 |
2020 |
Puerarin attenuates the endothelial-mesenchymal transition induced by oxidative stress in human coronary artery endothelial cells through PI3K/AKT pathway. |
EndMT, PI3K |
| 69 |
2020 |
Salidroside downregulates microRNA‑133a and inhibits endothelial cell apoptosis induced by oxidized low‑density lipoprotein. |
AS, Sal |
| 70 |
2020 |
Statin rosuvastatin inhibits apoptosis of human coronary artery endothelial cells through upregulation of the JAK2/STAT3 signaling pathway. |
JAK, STAT |
| 71 |
2020 |
The role of Ca2+/NFAT in Dysfunction and Inflammation of Human Coronary Endothelial Cells induced by Sera from patients with Kawasaki disease. |
CsA, KD |
| 72 |
2019 |
Core-Shell Polymer-Based Nanoparticles Deliver miR-155-5p to Endothelial Cells. |
ECs, ER, miRNAs, NPs, PIBCA |
| 73 |
2019 |
Differential responses of endothelial cells on three-dimensional scaffolds to lipopolysaccharides from periodontopathogens. |
Aa, LPS, Pg |
| 74 |
2019 |
Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor alpha-Stimulated Human Coronary Arterial Endothelial Cells. |
DAPA, EMPA, FACS, HUVECs, NO, SGLT2i's, TNF-alpha |
| 75 |
2019 |
Endothelial cells from different anatomical origin have distinct responses during SNAIL/TGF-beta2-mediated endothelial-mesenchymal transition. |
EndMT, TGF-beta |
| 76 |
2019 |
Ethanol enhances endothelial ionic currents and nitric oxide release via intermediate-conductance calcium-activated potassium channel. |
A2AR, KCa, PKA |
| 77 |
2019 |
Induction of decay accelerating factor and membrane cofactor protein by resveratrol attenuates complement deposition in human coronary artery endothelial cells. |
HO |
| 78 |
2019 |
Interleukin-37: The Effect of Anti-Inflammatory Response in Human Coronary Artery Endothelial Cells. |
IL-37 |
| 79 |
2019 |
Iodide modulates protein damage induced by the inflammation-associated heme enzyme myeloperoxidase. |
HOCl, MPO |
| 80 |
2019 |
Long noncoding RNA expression analysis reveals the regulatory effects of nitinol-based nanotubular coatings on human coronary artery endothelial cells. |
CVD, EC, lncRNAs, mRNAs, qRT-PCR, TAF1, TBP |
| 81 |
2019 |
MEF2A alters the proliferation, inflammation-related gene expression profiles and its silencing induces cellular senescence in human coronary endothelial cells. |
DEGs, GO, KEGG, MEF2A, siRNA |
| 82 |
2019 |
MiR-223-3p Alleviates Vascular Endothelial Injury by Targeting IL6ST in Kawasaki Disease. |
CAWS, ICAM-1, IL-6, IL-6ST, KD, p-STAT3, STAT3, UTR |
| 83 |
2019 |
miR-34a-5p was involved in chronic intermittent hypoxia-induced autophagy of human coronary artery endothelial cells via Bcl-2/beclin 1 signal transduction pathway. |
AV, Bcl-2, CIH, miR-34a-5p, miRNAs, OSAHS |
| 84 |
2019 |
Novel gene regulatory networks identified in response to nitro-conjugated linoleic acid in human endothelial cells. |
CLA, EC, FAs, NO |
| 85 |
2019 |
Production of bioactive recombinant human myeloid-derived growth factor in Escherichia coli and its mechanism on vascular endothelial cell proliferation. |
MYDGF, rh |
| 86 |
2019 |
Renin-angiotensin system inhibitor attenuates oxidative stress induced human coronary artery endothelial cell dysfunction via the PI3K/AKT/mTOR pathway. |
ROS |
| 87 |
2019 |
The Ratio of Factor VIIa:Tissue Factor Content within Microvesicles Determines the Differential Influence on Endothelial Cells. |
TF |
| 88 |
2019 |
Three-Layered Silk Fibroin Tubular Scaffold for the Repair and Regeneration of Small Caliber Blood Vessels: From Design to in vivo Pilot Tests. |
HAAFs, HASMCs, SF |
| 89 |
2019 |
Trimethylamine N-oxide promotes tissue factor expression and activity in vascular endothelial cells: A new link between trimethylamine N-oxide and atherosclerotic thrombosis. |
CVD, STEMI, TF, TMAO |
| 90 |
2019 |
Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor. |
AUDA, EETs, IL, IVIG, KD, MMP, sEH, TNF |
| 91 |
2018 |
Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling. |
HDAC, MIs, Wisp-1 |
| 92 |
2018 |
Antibacterial mechanisms of a novel type picosecond laser-generated silver-titanium nanoparticles and their toxicity to human cells. |
HDFc, NPs |
| 93 |
2018 |
Cardioprotective Effects of Puerarin-V on Isoproterenol-Induced Myocardial Infarction Mice Is Associated with Regulation of PPAR-Upsilon/NF-kappaB Pathway. |
ECG, ISO, LPS, MI, PCR |
| 94 |
2018 |
Cell-Specific Protective Signaling Induced by the Novel AT2R-Agonist NP-6A4 on Human Endothelial and Smooth Muscle Cells. |
CI, DOXO, hCAVSMCs, ROS, RTCA |
| 95 |
2018 |
Down-regulation of lncRNA OGFRP1 induces autophagy and growth inhibition by AKT/mTOR signaling pathway in HCAECs. |
lncRNAs |
| 96 |
2018 |
Effects of everolimus and HLA-G on cellular proliferation and neutrophil adhesion in an in vitro model of cardiac allograft vasculopathy. |
CAV, HCASMC, HLA-G |
| 97 |
2018 |
Eikenella corrodens lipopolysaccharide stimulates the pro-atherosclerotic response in human coronary artery endothelial cells and monocyte adhesion. |
ERK, GM-CSF, ICAM-1, IL-8, LPS, MCP-1, NF-kappaB, TLRs |
| 98 |
2018 |
Ghrelin attenuates myocardial fibrosis after acute myocardial infarction via inhibiting endothelial-to mesenchymal transition in rat model. |
AMI, EndMT, LAD, MF |
| 99 |
2018 |
Hyperbaric oxygen boosts long noncoding RNA MALAT1 exosome secretion to suppress microRNA-92a expression in therapeutic angiogenesis. |
HBO, MALAT1 |
| 100 |
2018 |
Monocyte-Derived Interleukin-1beta As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease. |
IL-1beta, IVIG, KD, LPS, RAGE, TLR4 |
|
A Search Service for Abbreviation / Long Form
